Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Timothy Oakley"'
Autor:
Ian M Anderson, Andrew Blamire, Tim Branton, Sabrina Brigadoi, Ross Clark, Darragh Downey, Graham Dunn, Andrew Easton, Rebecca Elliott, Clare Elwell, Katherine Hayden, Fiona Holland, Salman Karim, Jo Lowe, Colleen Loo, Rajesh Nair, Timothy Oakley, Antony Prakash, Parveen K Sharma, Stephen R Williams, R Hamish McAllister-Williams
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 4, Iss 2 (2017)
Background: Electroconvulsive therapy (ECT) is the most effective acute treatment for severe depression, but there are concerns about its adverse cognitive effects. ECT may impair cognition through stimulation of glutamate receptors, and preliminary
Externí odkaz:
https://doaj.org/article/e8f7610ed14c41008f3217830aa334ab
Autor:
Andrew M. Blamire, Katherine Hayden, Graham Dunn, Tim Branton, Antony Prakash, Salman Karim, Claire Blakeley, Fiona Holland, Stephen R. Williams, Darragh Downey, Rebecca Elliott, Graham Spencer, Ross Clark, Katherine Crosby, Colleen Loo, Liam Trevithick, Rajesh Nair, Amanda Watson, Clare E. Elwell, R. Hamish McAllister-Williams, J P Lowe, Francesca Williams, Aisha Perkis, Audrey Williamson, Timothy Oakley, Ian M. Anderson, Andrew Easton, Parveen K Sharma
Publikováno v:
The Lancet. Psychiatry
Anderson, I M, Blamire, A, Branton, T, Clark, R, Downey, D, Dunn, G, Easton, A, Elliott, R, Elwell, C, Hayden, K, Holland, F, Karim, S, Loo, C, Lowe, J, Nair, R, Oakley, T, Prakash, A, Sharma, P K, Williams, S & McAllister-Williams, R H 2017, ' Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT) : A multicentre, double-blind, randomised, parallel-group, superiority trial ', The Lancet Psychiatry, vol. 4, no. 5, pp. 365–377 . https://doi.org/10.1016/S2215-0366(17)30077-9
Anderson, I M, Blamire, A, Branton, T, Clark, R, Downey, D, Dunn, G, Easton, A, Elliott, R, Elwell, C, Hayden, K, Holland, F, Karim, S, Loo, C, Lowe, J, Nair, R, Oakley, T, Prakash, A, Sharma, P K, Williams, S & McAllister-Williams, R H 2017, ' Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT) : A multicentre, double-blind, randomised, parallel-group, superiority trial ', The Lancet Psychiatry, vol. 4, no. 5, pp. 365–377 . https://doi.org/10.1016/S2215-0366(17)30077-9
Summary Background The use of electroconvulsive therapy (ECT) is limited by concerns about its cognitive adverse effects. Preliminary evidence suggests that administering the glutamate antagonist ketamine with ECT might alleviate cognitive adverse ef
Autor:
Clare E. Elwell, Ross Clark, Colleen Loo, Darragh Downey, Rajesh Nair, J P Lowe, R. Hamish McAllister-Williams, Fiona Holland, Stephen R. Williams, Graham Dunn, Tim Branton, Ian M. Anderson, Antony Prakash, Salman Karim, Andrew M. Blamire, Timothy Oakley, Katherine Hayden, Andrew Easton, Rebecca Elliott, Sabrina Brigadoi, Parveen K Sharma
Publikováno v:
Anderson, I M, Blamire, A, Branton, T, Brigadoi, S, Clark, R, Downey, D, Dunn, G, Easton, A, Elliott, R, Elwell, C, Holland, F, Lowe, J, Loo, C, Nair, R, Oakley, T, Prakash, A, Sharma, P K, Williams, S R & McAllister-Williams, R H 2017, ' Randomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study) ', Efficacy and Mechanism Evaluation, vol. 4, no. 2, pp. 1-112 . https://doi.org/10.3310/eme04020
Efficacy and Mechanism Evaluation, Vol 4, Iss 2 (2017)
Efficacy and Mechanism Evaluation, Vol 4, Iss 2 (2017)
BackgroundElectroconvulsive therapy (ECT) is the most effective acute treatment for severe depression, but there are concerns about its adverse cognitive effects. ECT may impair cognition through stimulation of glutamate receptors, and preliminary ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fc1b63d2de81fd5578520bb813ea951
https://doi.org/10.3310/eme04020
https://doi.org/10.3310/eme04020
Autor:
Tim Branton, Fiona Holland, Ian M. Anderson, Timothy Oakley, J P Lowe, Colleen Loo, Darragh Downey, Andrew M. Blamire, Salman Karim, Rajesh Nair, Graham Dunn, Andrew Easton, Antony Prakash, Katherine Hayden, Parveen K Sharma, Stephen R. Williams, Ross Clark, Rebecca Elliott, Liam Trevithick, Clare Ellwell, R. Hamish McAllister-Williams
Publikováno v:
BMC Psychiatry
Trevithick, L, McAllister-Williams, R H, Blamire, A, Branton, T, Clark, R, Downey, D, Dunn, G, Easton, A, Elliott, R, Ellwell, C, Hayden, K, Holland, F, Karim, S, Lowe, J, Loo, C, Nair, R, Oakley, T, Prakash, A, Sharma, P K, Williams, S R & Anderson, I M 2015, ' Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study) ', BMC Psychiatry, vol. 15, no. 257 . https://doi.org/10.1186/s12888-015-0641-4, https://doi.org/10.1186/s12888-015-0641-4
Trevithick, L, McAllister-Williams, R H, Blamire, A, Branton, T, Clark, R, Downey, D, Dunn, G, Easton, A, Elliott, R, Ellwell, C, Hayden, K, Holland, F, Karim, S, Lowe, J, Loo, C, Nair, R, Oakley, T, Prakash, A, Sharma, P K, Williams, S R & Anderson, I M 2015, ' Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study) ', BMC Psychiatry, vol. 15, no. 257 . https://doi.org/10.1186/s12888-015-0641-4, https://doi.org/10.1186/s12888-015-0641-4
BACKGROUND: There is a robust empirical evidence base supporting the acute efficacy of electroconvulsive therapy (ECT) for severe and treatment resistant depression. However, a major limitation, probably contributing to its declining use, is that ECT